ALPS Global News – March 12, 2025 🌍📰
Welcome to ALPS Global News, your trusted source for the latest updates on global affairs, business, healthcare, and scientific breakthroughs. Here are today’s top stories:
Malaysia Introduces Six-Month Investor Travel Pass
The Malaysian government has announced a special six-month investor travel pass aimed at attracting foreign investors and business leaders. Home Minister Saifuddin Nasution Ismail revealed that the initiative, set to launch on April 1, will allow eligible investors to stay in Malaysia for six months, with the possibility of an extension. The Xpats Gateway platform will facilitate applications, making the process smoother and more efficient. This move is expected to enhance foreign investment opportunities and strengthen Malaysia’s business landscape.
Breakthrough HIV Prevention Jab Passes Key Safety Trial
A groundbreaking annual HIV prevention injection, Lenacapavir, has successfully passed a key safety trial, according to researchers in The Lancet. Unlike traditional daily PrEP pills, this long-acting shot requires just one injection per year, significantly improving accessibility and adherence, especially in high-risk populations. This marks a major advancement in HIV prevention and could transform global healthcare efforts.
South Korea’s Trade Minister Heads to Washington for Tariff Talks
In a bid to address growing trade concerns, South Korea’s Trade Minister, Cheong In-kyo, will travel to Washington, D.C., on March 13-14 for discussions with U.S. officials. The talks will focus on tariff disputes, investment policies, and potential trade adjustments ahead of President Trump’s upcoming trade report. With increasing tensions over new U.S. tariffs, South Korea aims to protect its economic interests while fostering strong trade relations with the U.S.
ALPS’ Latest Stem Cell Study Marks a Breakthrough in Regenerative Medicine
In a major medical breakthrough, ALPS has unveiled its latest stem cell research, published in PLOS Journal. The study confirms the safety and effectiveness of UC-MSC (Umbilical Cord Mesenchymal Stem Cells) in regenerative medicine. This milestone further solidifies ALPS’ position as a global leader in stem cell therapy, offering new hope for patients seeking advanced medical treatments for various degenerative conditions.
📺 Watch the full news report here
Stay informed with ALPS Global News for the latest updates on business, healthcare, and international affairs. Don’t miss out on the news that matters!
🔔 Follow us for more updates!
